Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474834 · ClinicalTrials.gov registry record
Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study
A clinical trial of Breast Cancer, sponsored by Mayo Clinic.
- Active
- Registry status
- 737
- Enrollment target
- 5
- Study locations
NCT04474834: Active study of Breast Cancer, sponsored by Mayo Clinic.
NCT04474834 is a study of Breast Cancer that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 737 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (74% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04474834, a study of Breast Cancer, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 737 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer.
Conditions Studied
Interventions
- GENETIC Polygenic Risk Score
Study Locations (5)
Arizona
- Mayo Clinic - Scottsdale
Florida
- Mayo Clinic - Jacksonville
Illinois
- Northwestern University - Evanston
Minnesota
- Mayo Clinic in Rochester - Rochester
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 737 participants |
| Start Date | 2019-10-17 |
| Est. Completion | 2029-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474834
The ClinicalTrials.gov registry entry for NCT04474834 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 737 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (74% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Polygenic Risk Score is the first listed.
NCT04474834 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT04474834 about?
NCT04474834 is a clinical study titled "Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study". The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) medications to preve...
What is the current status of trial NCT04474834?
This trial is currently active not recruiting. The enrollment target is 737 participants. The study started on 2019-10-17. Estimated completion is 2029-12-15.
What conditions does trial NCT04474834 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT04474834?
The interventions under investigation include: Polygenic Risk Score (GENETIC).
Who is sponsoring clinical trial NCT04474834?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04474834 being conducted?
This trial has 5 study locations across Arizona, Florida, Illinois, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.